UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000012030
Receipt No. R000014061
Scientific Title A Phase II study of pertuzumab+trastuzumab+capecitabine in Patients with taxans and trastuzumab refractory for advanced or recurrent breast cancer
Date of disclosure of the study information 2013/10/15
Last modified on 2017/11/30 18:10:03

No. Disposal Last modified on Item of update
1 Insert 2013/10/14 16:23:26
2 Update 2017/11/30 18:10:03 UMIN ID1


Contact us.